KT

Kirti Talakshi Shah

Active Director Director DIN 00250253
DIN 00250253 First appointment Feb 1991 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Feb 1991
Shareholding value •••• Premium profile

About Kirti Talakshi Shah

Data last updated:

Kirti Talakshi Shah is a Director at Ciron Drugs And Pharmaceuticals Private Limited (since 2005), Director at Cho-Spn Lifescience And Research Private Limited (since 1991) and Director at Oboi Laboratories Pvt Ltd (since 1995), and holds 1 more current directorship. The companies operate in Pharma and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹305 Cr; the largest is Ciron Drugs And Pharmaceuticals Private Limited at ₹305 Cr (FY 2024). Earlier, Kirti Talakshi Shah was a Director at Ciron Cleantech Private Limited (from 2011) and Director at Ciron Pharmatech Private Limited (from 2011).

DIN 00250253
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 1991
Oldest Company Age 41 yrs
Largest company Ciron Drugs And Pharmaceuticals Private Limited · ₹305 Cr (FY 2024)
Combined revenue ₹305 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jun 20051990₹305 Cr (FY 2024)Active
Director28 Feb 19911990₹7.5 Lakh (FY 2024)Active
Oboi Laboratories Pvt Ltd U99999MH1985PTC036765
Director01 Nov 19951985₹67,430 (FY 2024)Active
Designated Partner14 Aug 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ciron Cleantech Private Limited U29221MH2011PTC214164
Director28 Feb 20112011Strike Off
Ciron Pharmatech Private Limited U33111MH2011PTC213965
Director24 Feb 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acco Commercial Llp
Cho-Spn Lifescience And Research Private Limited
Ciron Drugs And Pharmaceuticals Private Limited
Ciron Cleantech Private Limited
Premium access

Shareholding and investment profile for Kirti Talakshi Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kirti Talakshi Shah

Kirti Talakshi Shah currently holds 4 directorships: Ciron Drugs And Pharmaceuticals Private Limited (Director, since 18 Jun 2005, revenue ₹305 Cr (FY 2024)); Cho-Spn Lifescience And Research Private Limited (Director, since 28 Feb 1991, revenue ₹7.5 Lakh (FY 2024)); Oboi Laboratories Pvt Ltd (Director, since 01 Nov 1995, revenue ₹67,430 (FY 2024)); Acco Commercial Llp (Designated Partner, since 14 Aug 2021).

Kirti Talakshi Shah was first appointed on 28 Feb 1991 as Director at Cho-Spn Lifescience And Research Private Limited. The most recent appointment on record is 14 Aug 2021 at Acco Commercial Llp.

The 3 current companies of Kirti Talakshi Shah that report revenue have a combined latest revenue of ₹305 Cr: Ciron Drugs And Pharmaceuticals Private Limited ₹305 Cr (FY 2024); Cho-Spn Lifescience And Research Private Limited ₹7.5 Lakh (FY 2024); Oboi Laboratories Pvt Ltd ₹67,430 (FY 2024).

Kirti Talakshi Shah held 2 earlier board appointments: Ciron Cleantech Private Limited (Director, from 28 Feb 2011); Ciron Pharmatech Private Limited (Director, from 24 Feb 2011).

The current boards of Kirti Talakshi Shah's companies include Biswajit Paul (Ciron Drugs And Pharmaceuticals Private Limited), Keyur Ratanshi Shah (Ciron Drugs And Pharmaceuticals Private Limited), Keyur Ratanshi Shah (Ciron Drugs And Pharmaceuticals Private Limited), Madan Trimbak Hiwale (Ciron Drugs And Pharmaceuticals Private Limited), Samir Ratanshi Shah (Ciron Drugs And Pharmaceuticals Private Limited), Dhaval Kirti Shah (Acco Commercial Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available